Insider Trading & Ownership of Peter Kolchinsky

Location
Boston, MA
Summary
The estimated net worth of Peter Kolchinsky is at least $670,397,356 dollars as of 30 Jun 2021. Peter Kolchinsky is the Director, 10%+ Owner of Artiva Biotherapeutics, Inc. and owns shares of Artiva Biotherapeutics, Inc. (ARTV) stock worth about $200.15M. Peter Kolchinsky is the Director, 10%+ Owner of Wave Life Sciences Ltd. and owns shares of Wave Life Sciences Ltd. (WVE) stock worth about $175.34M. Peter Kolchinsky is the Director of Mineralys Therapeutics, Inc. and owns shares of Mineralys Therapeutics, Inc. (MLYS) stock worth about $140.74M. Peter Kolchinsky is the Director, 10%+ Owner of Forma Therapeutics Holdings, Inc. and owns shares of Forma Therapeutics Holdings, Inc. stock worth about $45.52M. Peter Kolchinsky is the Director, 10%+ Owner of Vor Biopharma Inc. and owns shares of Vor Biopharma Inc. (VOR) stock worth about $37.88M. Peter Kolchinsky is the Director, 10%+ Owner of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $28.45M. Peter Kolchinsky is the 10%+ Owner of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $22.15M. Peter Kolchinsky is the Chief Executive Officer, Director of Therapeutics Acquisition Corp. and owns shares of POINT Biopharma Global Inc. stock worth about $13.67M. Peter Kolchinsky is the 10%+ Owner of Adicet Bio, Inc. and owns shares of Adicet Bio, Inc. (ACET) stock worth about $6.23M. Peter Kolchinsky is the 10%+ Owner of Werewolf Therapeutics, Inc. and owns shares of Werewolf Therapeutics, Inc. (HOWL) stock worth about $260K.
Signature
/s/ Matthew Hammond as Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Peter Kolchinsky and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Peter Kolchinsky has 12 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $670,397,356.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Artiva Biotherapeutics, Inc. ($200,149,794).
  • Past-year value change for that position: +$99,999,765.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Peter Kolchinsky

ACET Forms 3/4/5

Adicet Bio, Inc.

Relationship
10%+ Owner
Holdings value
$6,226,197
Past year net change
+$1,603,934
Change %
+35%
Report period
27 Apr 2026

Insider Transactions Reported by Peter Kolchinsky:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .